Pharmafile Logo
Pharmafocus logo
Advanced Search

Goldacre

Showing 15 posts of 39 posts found.

nhs_parliament_2_1

MPs ‘surprised and concerned’ over data transparency

January 3, 2014
Medical Communications, Sales and Marketing Cochrane, Godlee, Goldacre, Roche, Tamiflu, transparency

News

Europe to vote on greater trial transparency

December 17, 2013
Research and Development, Sales and Marketing EU, Europe, Goldacre, alltrials, transparency

Pharma companies and academic researchers will be obliged to upload the results of all their European clinical trials to a …

News
EMA image

Court annuls EMA data decision

December 5, 2013
Medical Communications, Sales and Marketing AbbVie, EMA, Goldacre, InterMune, alltrials, transparency

The European Court of Justice has annulled interim injunctions against the European Medicines Agency issued earlier this year after AbbVie …

News

UPDATED: Pfizer first on trial transparency

December 5, 2013
Medical Communications, Sales and Marketing EMA, Goldacre, Pfizer, alltrials, transparency

News
EU flag image

EU rethinks regulation

December 2, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Goldacre, Les Rose, MHRA, regulation

What has happened to the science in clinical research? Well, it is still there, but with the explosion in the …

Feature

Unpublished trials ‘violates ethical obligation’ to patients

October 30, 2013
Research and Development, Sales and Marketing BMJ, Goldacre, all trials, trials

A new study published in the BMJ has found almost one in three (29%) of large clinical trials remain unpublished …

News
leo pharma

LEO Pharma to release clinical trial data

October 24, 2013
Research and Development, Sales and Marketing Goldacre, LEO Pharma, all trials, transparency

LEO Pharma has announced that it will start releasing clinical trial data from studies dating back to almost 25 years …

News
ABPI image

ABPI publishes trial disclosure ‘toolkit’

August 15, 2013
Medical Communications, Sales and Marketing ABPI, EFPIA, Goldacre, transparency

The ABPI has today launched a new clinical trial disclosure toolkit to help pharma companies meet data transparency requirements.  The …

News
NICE image

AllTrials campaign releases manifesto

August 9, 2013
Medical Communications, Research and Development, Sales and Marketing Bad pharma, GSK, Goldacre, NICE, transparency

The UK clinical trial transparency initiative AllTrials has released its first detailed manifesto as it looks to ramp up pressure …

News
richard bergstrom image

Pharma groups want limited data release

July 24, 2013
Research and Development, Sales and Marketing EFPIA, Goldacre, PhRMA, all trials, transparency

The two main US and European pharma lobby groups have released a joint statement saying they welcome independent reviews of …

News
Howe and Willetts image

UK government cautious on trial transparency

June 4, 2013
Research and Development, Sales and Marketing Goldacre, UK, alltrials, transparency

Two ministers with responsibility for life sciences in the UK struck a cautious note over clinical trial transparency at an …

News
Europe image

Europe votes yes on greater trial transparency

June 3, 2013
Research and Development, Sales and Marketing Europe, Goldacre, alltrials, transparency

Europe has taken one step closer to increasing clinical trial transparency on the continent after MEPs voted yes on new …

News
Goldacre image

Bad pharma, good pharma: an insider’s view

May 30, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bad pharma, Goldacre, NICE, transparancy

Most people in the pharmaceutical industry, particularly in the UK, will be well-acquainted with Ben Goldacre by now. He published his …

Feature
NICE image

Grant NICE greater trial data access – report

May 29, 2013
Research and Development, Sales and Marketing Goldacre, NICE, transparency, trials

A new report by the National Audit Office says NICE should be given greater powers to access clinical trial data. …

News
abpi_reception

‘No consensus’ on transparency

April 22, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, Goldacre, Whitehead, all trials, transparency

An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026